文献速递神经免疫

美国大型队列中的儿童多发性硬化严重程度评分

Pediatric Multiple Sclerosis Severity Score in a large US cohort.
PubMed 文献 · Neurology · 2020-07-20

该研究基于美国12个儿童多发性硬化中心的873例儿童起病多发性硬化(POMS)患者,回顾性分析其残疾评分,计算儿童多发性硬化严重程度评分(Ped-MSSS),并与成人数据比较。结果显示POMS患者EDSS评分低于成人起病MS,Ped-MSSS模型可作为临床评估疾病严重程度和残疾累积的替代工具。

要点

  • POMS患者EDSS评分普遍低于成人起病MS。
  • Ped-MSSS评分随诊断年限增加进展较成人MSSS缓慢。
  • 运动复发史和首年EDSS是疾病进展的显著预测因素。

核心结论

  • POMS患者EDSS评分低于成人起病MS,Ped-MSSS模型可用于临床评估疾病严重程度和残疾累积。

研究设计与样本

  • 多中心回顾性分析,纳入美国12个儿童MS中心前瞻性收集的873例POMS患者数据。

主要发现

  • 在任何时间点,52%、19.4%和1.5%的患者分别达到EDSS 2.0、3.0和6.0。
  • Ped-MSSS与成人MSSS比较显示,随着EDSS评分与诊断后年限差距增大,Ped-MSSS进展更慢。
  • POMS队列中EDSS 2.0、3.0和6.0的十分位评分在2年、5年、10年分别为8.00/9.46/9.94、7.86/9.39/9.91和7.32/9.01/9.86。
  • EDSS和Ped-MSSS模型中疾病进展的显著预测因素包括曾发生运动复发和首年EDSS。
  • 符号数字模态测试(SDMT)评分与疾病活动持续时间和脑功能评分呈负相关。

临床怎么用

  • Ped-MSSS可作为儿童多发性硬化临床评估疾病严重程度和残疾累积的替代评分工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize disease severity and distribution of disability in pediatric-onset multiple sclerosis (POMS) and to develop an optimized modeling scale for measuring disability, we performed a multicenter retrospective analysis of disability scores in 873 persons with POMS over time and compared this to previously published data in adults with multiple sclerosis (MS). METHODS: This was a retrospective analysis of prospectively collected data collected from 12 centers of the US Network of Pediatric MS Centers. Patients were stratified by the number of years from first symptoms of MS to Expanded Disability Status Scale (EDSS) assessment and an MS severity score (Pediatric Multiple Sclerosis Severity Score [Ped-MSSS]) was calculated per criteria developed by Roxburgh et al. in 2005. RESULTS: In total, 873 patients were evaluated. In our cohort, 52%, 19.4%, and 1.5% of all patients at any time point reached an EDSS of 2.0, 3.0, and 6.0. Comparison of our Ped-MSSS scores and previously published adult Multiple Sclerosis Severity Scores (MSSS) showed slower progression of Ped-MSSS with increasing gaps between higher EDSS score and years after diagnosis. Decile scores in our POMS cohort for EDSS of 2.0, 3.0, and 6.0 were 8.00/9.46/9.94, 7.86/9.39/9.91, and 7.32/9.01/9.86 at 2, 5, and 10 years, respectively. Notable predictors of disease progression in both EDSS and Ped-MSSS models were ever having a motor relapse and EDSS at year 1. Symbol Digit Modalities Test (SDMT) scores were inversely correlated with duration of disease activity and cerebral functional score. CONCLUSIONS: Persons with POMS exhibit lower EDSS scores compared to persons with adult-onset MS. Use of a Ped-MSSS model may provide an alternative to EDSS scoring in clinical assessment of disease severity and disability accrual.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Santoro JD, Waltz M, Aaen G, et al. Pediatric Multiple Sclerosis Severity Score in a large US cohort. Neurology. 2020. PMID: 32690790. doi:10.1212/WNL.0000000000010414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。